Recombinant Human CTPS2 Protein, N-His

Description of Recombinant Human CTPS2 Protein, N-His

Title: Introduction to Recombinant Human CTPS2 Protein

Recombinant human CTPS2 protein, also known as CTP synthase 2, is a key enzyme in the pyrimidine biosynthesis pathway. It is involved in the conversion of uridine triphosphate (UTP) to cytidine triphosphate (CTP), an essential nucleotide for DNA and RNA synthesis. In this article, we will explore the structure, activity, and applications of recombinant human CTPS2 protein.

Title: Structure of Recombinant Human CTPS2 Protein

Recombinant human CTPS2 protein is a homotetramer, meaning it is composed of four identical subunits. Each subunit consists of two domains: an N-terminal glutamine amidotransferase (GAT) domain and a C-terminal CTP synthase (CTPS) domain. The GAT domain is responsible for the glutamine-dependent amidotransferase activity, while the CTPS domain catalyzes the conversion of UTP to CTP. The four subunits are arranged in a head-to-tail fashion, forming a central channel where the catalytic site is located.

Title: Activity of Recombinant Human CTPS2 Protein

Recombinant human CTPS2 protein plays a crucial role in the regulation of cellular CTP levels. It is highly conserved among species and is essential for cell growth and proliferation. The enzyme activity of CTPS2 is regulated by the availability of its substrate, glutamine, and the allosteric inhibitor, CTP. When glutamine is abundant, CTPS2 activity is stimulated, leading to increased CTP production. On the other hand, high levels of CTP inhibit CTPS2 activity, providing a negative feedback mechanism to maintain cellular CTP levels.

Title: Applications of Recombinant Human CTPS2 Protein

Recombinant human CTPS2 protein has a wide range of applications in both research and therapeutic settings. One of its main uses is in the production of recombinant proteins. CTPS2 is often co-expressed with target proteins in recombinant protein expression systems to increase CTP levels and improve protein yield. Additionally, CTPS2 has been shown to play a role in the regulation of immune responses, making it a potential target for immunomodulatory therapies.

Title: Recombinant Human CTPS2 Protein as an Antigen

CTPS2 has been identified as an antigen in autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Autoantibodies against CTPS2 have been found in the serum of patients with these conditions, suggesting a potential role of CTPS2 in the pathogenesis of these diseases. Recombinant human CTPS2 protein can be used as an antigen in diagnostic tests to detect these autoantibodies and aid in the diagnosis of SLE and RA.

Title: Future Directions and Conclusion

The study of recombinant human CTPS2 protein is an active area of research, and there is still much to be discovered about its structure, activity, and applications. Further studies on the regulation of CTPS2 activity and its role in various diseases may lead to the development of new therapeutic strategies. Additionally, the use of recombinant CTPS2 protein in protein expression systems and as an antigen in diagnostic tests holds great promise for future advancements in biotechnology and medicine.

In conclusion, recombinant human CTPS2 protein is a vital enzyme involved in the pyrimidine biosynthesis pathway. Its structure and activity have been extensively studied, and it has various applications in research and therapeutics. As our understanding of CTPS2 continues to grow, we can expect to see new developments and advancements in the fields of biotechnology and medicine.